Dmitry Glukhovsky, author of the Metro franchise, has confirmed that Metro 2039's protagonist main character, The Stranger, ...
The Stranger replacing Artyom has major implications for Metro 2039, but is that a bad thing?
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
NEWARK, CA / ACCESS Newswire / April 16, 2026 / Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on ...
Goldman Sachs analyst Richard Law initiated coverage of Protagonist Therapeutics (PTGX) with a Neutral rating and $47 price target Both of the company’s Phase 3 assets can succeed commercially, but ...
Protagonist Therapeutics has delivered strong Phase 3 data for both icotrokinra (psoriasis) and rusfertide (polycythemia vera), supporting blockbuster potential. Lucrative partnerships with Johnson & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results